Core Viewpoint - The appointment of David Swetlow as Chief Financial Officer (CFO) is a strategic move to strengthen Ventripoint's leadership team and support the global rollout of its AI-powered VMS+™ cardiac imaging platform [2][4][7]. Leadership Changes - David Swetlow, CPA, CA, iGP, has been appointed as CFO, effective immediately, marking a significant step in Ventripoint's transition into a growth phase [2][3]. - The company expresses gratitude to outgoing CFO Jimmy Jeon for his contributions during a critical transition period [5]. Strategic Focus - Swetlow's extensive experience in high-growth medical technology and life sciences will be crucial for Ventripoint as it aims to enhance its financial strategy, capital markets, and operational performance [3][6]. - The company is focused on executing a refreshed commercial strategy to scale its technology, strengthen global partnerships, and explore new markets for revenue growth [4][7]. Technology and Market Position - Ventripoint's VMS+™ technology platform is positioned as a leader in cardiac imaging innovation, utilizing AI to provide cost-effective and timely diagnostics for at-risk cardiac patients [7][9]. - The VMS products leverage proprietary Knowledge Based Reconstruction technology, offering accurate volumetric cardiac measurements comparable to MRI, thus enhancing cardiologists' confidence in patient management [9]. Compensation and Incentives - The Board of Directors has granted Mr. Swetlow 1,000,000 options exercisable at $0.11 with a term of 10 years, vesting over 12 months, aligning his interests with the company's growth objectives [8].

Former Apple Health VP to Guide C10 Labs and AI-Healthcare Venture Building from Kendall SquareCAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire-PRWeb/ -- C10 Labs today announced Dr. Michael O'Reilly as Chief Medical Advisor. The appointment strengthens C10's capacity to build ventures that convert AI research into practical healthcare applications.Dr. O'Reilly joins as C10 Labs expands its physical AI initiatives—ventures connecting digital intelligence with real-world Applied AI medical platforms and devices. H ...

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) ...

December 2, 2025 11:03 AM GMT Medical Technology | North America 2026 Outlook: A Good Prognosis for MedTech MedTech stock-specific volatility & performance dispersion escalated once again in 2025 (and shows no signs of stopping). However, we think major product cycles and a supportive hospital spending environment combined with trough valuation vs. the S&P makes for a solid industry setup into '26. Key Takeaways Going into 2026, MedTech looks well-positioned on several fronts. At a high level, we think fund ...

PresentationAdam MaederPiper Sandler & Co., Research Division All right. We're live here, so we're going to get going. Welcome to the 2025 Piper Sandler Healthcare Conference. My name is Adam Maeder. I'm one of the Med Tech analyst here at Piper. Very pleased to introduce the team from Inspire Medical. With us, we have Tim Herbert, Chairman and CEO; and Ezgi Yagci, from Investor Relations. Thanks so much for joining us. ...

AxoGen (NasdaqCM:AXGN) FY Conference December 02, 2025 12:30 PM ET Speaker0All right. Hi, everyone. My name is Ana Renzi. I'm one of the associates on the med tech team here at Piper. Today we're pleased to have Mike Dale from Axogen, the CEO, give us a little presentation on the business. With that, I'll turn it over to you.Speaker1Thank you very much. Thanks to all of you for joining us today. Looking forward to sharing a little bit about our story. My name is Mike Dale. As she's mentioned, I've been with ...

Question-and-Answer SessionI guess maybe we can start just high level. You guys just reported last month. There's been a lot of noise in tools land on the positive side, which is nice in terms of some of the pharma conversation. Maybe just give us a lay of the land in terms of how you're feeling at the moment coming out of 3Q. Again, what the right way to think about some of the pharma news is and then what it might mean to you?Prahlad SinghCEO, President & Director Sure, Patrick. Thanks for the invite. It' ...

MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the company is expanding its development efforts into a new generation of consumer-grade AI pre-health screening mobile applications designed to help identify early warning signs of serious health conditions and encourage timely medical intervention. This initiative builds upon MDCE's previously announced breakthrough in early melanoma detection. ...

VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has entered into a second sales agreement for its BreathLogix unmanned alcohol screening technology with an existing European maritime shipping customer. Under this agreement, the Company will deliver an additional BreathLogix unit to enhance operational safety among cr ...

PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeSciencesAt ...